Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian Randomization study
View ORCID ProfileMarios K. Georgakis, View ORCID ProfileRainer Malik, View ORCID ProfileDipender Gill, View ORCID ProfileNora Franceschini, View ORCID ProfileCathie L. M. Sudlow, INVENT Consortium, CHARGE Inflammation Working Group, View ORCID ProfileMartin Dichgans
doi: https://doi.org/10.1101/19007682
Marios K. Georgakis
1Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University LMU, Munich, Germany
2Graduate School for Systemic Neurosciences (GSN), Ludwig-Maximilians-University LMU, Munich, Germany
MD, MScRainer Malik
1Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University LMU, Munich, Germany
PhDDipender Gill
3Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
MDNora Franceschini
4Department of Epidemiology, UNC Gillings Global School of Public Health, Chapel Hill, NC, USA
MD, MPHCathie L. M. Sudlow
3Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
5Institute for Genetics and Molecular Medicine, University of Edinburgh, UK
DPhilMartin Dichgans
1Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University LMU, Munich, Germany
6Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
7German Centre for Neurodegenerative Diseases (DZNE), Munich, Germany
MD
Data Availability
All analyses presented in the manuscript have been conducted with publically available data. The instruments extracted for IL6 signaling are available in Table 1, for other authors to replicate our findings and use them in future work.
Posted September 27, 2019.
Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian Randomization study
Marios K. Georgakis, Rainer Malik, Dipender Gill, Nora Franceschini, Cathie L. M. Sudlow, INVENT Consortium, CHARGE Inflammation Working Group, Martin Dichgans
medRxiv 19007682; doi: https://doi.org/10.1101/19007682
Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian Randomization study
Marios K. Georgakis, Rainer Malik, Dipender Gill, Nora Franceschini, Cathie L. M. Sudlow, INVENT Consortium, CHARGE Inflammation Working Group, Martin Dichgans
medRxiv 19007682; doi: https://doi.org/10.1101/19007682
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)